Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Nitsche

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Oncoimmunology|September 19, 2017
Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccinationAnnkristin Heine, Chrystel Flores, Heidrun Gevensleben, et al.
Annals of Surgery|January 9, 2013
Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancerMatthias Maak, Iris Simon, Ulrich Nitsche, et al.
Annals of Surgical Oncology|September 10, 2015
Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center ExperienceUlrich Nitsche, Patrick Wenzel, Jens T Siveke, et al.
Annals of Surgery|August 31, 2013
Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosisUlrich Nitsche, Anina Zimmermann, Christoph Späth, et al.
The Journal of Pathology|March 21, 2012
Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancerStephan Meding, Benjamin Balluff, Mareike Elsner, et al.
Plos One|May 17, 2014
Immune humanization of immunodeficient mice using diagnostic bone marrow aspirates from carcinoma patientsMelanie Werner-Klein, Judith Proske, Christian Werno, et al.
The Journal of Pathology|August 29, 2012
A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequencySun Tian, Paul Roepman, Vlad Popovici, et al.
Journal of Proteome Research|January 10, 2012
Tumor classification of six common cancer types based on proteomic profiling by MALDI imagingStephan Meding, Ulrich Nitsche, Benjamin Balluff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 16, 2014
MicroRNA classifier and nomogram for metastasis prediction in colon cancerInès J Goossens-Beumer, Remco S Derr, Henk P J Buermans, et al.
Journal of Cancer Research and Clinical Oncology|August 31, 2016
Prognosis of mucinous and signet-ring cell colorectal cancer in a population-based cohortUlrich Nitsche, Helmut Friess, Ayman Agha, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Oncoimmunology|September 19, 2017
Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccinationAnnkristin Heine, Chrystel Flores, Heidrun Gevensleben, et al.
Annals of Surgery|January 9, 2013
Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancerMatthias Maak, Iris Simon, Ulrich Nitsche, et al.
Annals of Surgical Oncology|September 10, 2015
Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center ExperienceUlrich Nitsche, Patrick Wenzel, Jens T Siveke, et al.
Annals of Surgery|August 31, 2013
Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosisUlrich Nitsche, Anina Zimmermann, Christoph Späth, et al.
The Journal of Pathology|March 21, 2012
Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancerStephan Meding, Benjamin Balluff, Mareike Elsner, et al.
Plos One|May 17, 2014
Immune humanization of immunodeficient mice using diagnostic bone marrow aspirates from carcinoma patientsMelanie Werner-Klein, Judith Proske, Christian Werno, et al.
The Journal of Pathology|August 29, 2012
A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequencySun Tian, Paul Roepman, Vlad Popovici, et al.
Journal of Proteome Research|January 10, 2012
Tumor classification of six common cancer types based on proteomic profiling by MALDI imagingStephan Meding, Ulrich Nitsche, Benjamin Balluff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 16, 2014
MicroRNA classifier and nomogram for metastasis prediction in colon cancerInès J Goossens-Beumer, Remco S Derr, Henk P J Buermans, et al.
Journal of Cancer Research and Clinical Oncology|August 31, 2016
Prognosis of mucinous and signet-ring cell colorectal cancer in a population-based cohortUlrich Nitsche, Helmut Friess, Ayman Agha, et al.
Pageof 7